Literature DB >> 11097226

Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study.

W S Samowitz1, K Curtin, D Schaffer, M Robertson, M Leppert, M L Slattery.   

Abstract

Some previous studies have demonstrated significant results between Ki-ras mutations and tumor stage, survival, and/or other clinical variables, whereas others have not. We therefore evaluated the significance of codons 12 and 13 Ki-ras mutations in a large population-based study of 1413 individuals with colon cancer. Ki-ras mutations were identified in approximately 32% of tumors. Codon 12 mutations were significantly more common in proximal than distal tumors (29.1% versus 20.5%; P < 0.01) and in tumors of advanced stage. Tumors from men were more likely to have transition mutations and codon 12 G-->A mutations. After adjusting for age and stage, the codon 13 G-->A mutation was associated with a 40% (95% confidence interval, 0.95-2.0) increase in short-term mortality from colon cancer. In conclusion, this population-based study demonstrates important relationships between Ki-ras mutations and stage, survival, tumor location, and gender.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097226

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  131 in total

1.  Left and right sided large bowel cancer.

Authors:  Susan Richman; Julian Adlard
Journal:  BMJ       Date:  2002-04-20

2.  Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer.

Authors:  Ulrike Haug; Elizabeth M Poole; Liren Xiao; Karen Curtin; David Duggan; Li Hsu; Karen W Makar; Ulrike Peters; Richard J Kulmacz; John D Potter; Lisel Koepl; Bette J Caan; Martha L Slattery; Cornelia M Ulrich
Journal:  Genes Chromosomes Cancer       Date:  2012-02-27       Impact factor: 5.006

3.  KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).

Authors:  Harry H Yoon; David Tougeron; Qian Shi; Steven R Alberts; Michelle R Mahoney; Garth D Nelson; Suresh G Nair; Stephen N Thibodeau; Richard M Goldberg; Daniel J Sargent; Frank A Sinicrope
Journal:  Clin Cancer Res       Date:  2014-03-31       Impact factor: 12.531

4.  K-RAS mutation profile in Puerto Rican patients with colorectal cancer: trends from April 2009 to January 2011.

Authors:  Yelitza Ruiz-Candelaria; Christine Miranda-Diaz; Robert F Hunter-Mellado
Journal:  Int J Biol Markers       Date:  2013-12-17       Impact factor: 2.659

Review 5.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

6.  Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Jennifer S Herrick; Roger K Wolff
Journal:  Mutat Res       Date:  2010-10-28       Impact factor: 2.433

7.  KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.

Authors:  Ju-Xiang Ye; Yan Liu; Yun Qin; Hao-Hao Zhong; Wei-Ning Yi; Xue-Ying Shi
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

8.  Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.

Authors:  Clare Abbenhardt; Elizabeth M Poole; Richard J Kulmacz; Liren Xiao; Karen Curtin; Rachel L Galbraith; David Duggan; Li Hsu; Karen W Makar; Bette J Caan; Lisel Koepl; Robert W Owen; Dominique Scherer; Christopher S Carlson; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

9.  Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Authors:  Martha L Slattery; Roger K Wolff; Karen Curtin; Frank Fitzpatrick; Jennifer Herrick; John D Potter; Bette J Caan; Wade S Samowitz
Journal:  Mutat Res       Date:  2008-10-15       Impact factor: 2.433

10.  KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.

Authors:  Vincenzo Dadduzio; Michele Basso; Sabrina Rossi; Tonia Cenci; Sara Capodimonti; Antonia Strippoli; Armando Orlandi; Eleonora Cerchiaro; Giovanni Schinzari; Alessandra Cassano; Maurizio Martini; Carlo Barone
Journal:  Mol Diagn Ther       Date:  2016-02       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.